Patent · US Active

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2

US10301278B2 · kind B2 · utility

8Cited by

1References

7Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Zhuoliang Chen · Cambridge, US
Michael Dore · Saint-Bruno-de-Montarville, CA
Jorge Garcia Fortanet · Wilmington, US
Rajesh Karki · Quincy, US
Mitsunori Kato · Cambridge, US
Matthew J. LaMarche · Reading, US
Lawrence Blas Perez · Silver Spring, US
Sarah Williams · Emeryville, US
Martin Sendzik · Belmont, US

Key dates

Filing date	Oct 5, 2017
Grant date	May 28, 2019
Priority date	—
Expiry date	Oct 5, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.